Case Study on Ayurvedic and Panchkarma Intervention for Chronic Kidney Disease in an Elderly Patient

Authors

  • Acharya Manish Director, Meditation Guru, Jeena Sikho Lifecare Limited, India
  • Gitika Chaudhary Senior Consultant, General Surgeon, BAMS, PGDIP, PGDGS, MS (Ayurveda), Jeena Sikho Lifecare Limited, India
  • Richa Senior Research officer and Consultant, BAMS, PGDIP, CICR, CAIM, CMW, Jeena Sikho Lifecare Limited, India
  • Suyash Pratap Singh Medical Superintendent, BAMS, PGDIP, DNYT, CCMC, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India
  • Manjeet Singh Consultant, BAMS, PGDIP, ACLS, CCDN, CICR, CAIM, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India
  • Pooja Consultant, BAMS, PGDIP, DAGO, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India

DOI:

https://doi.org/10.48165/ajm.2025.8.02.12

Keywords:

Ayurveda, Chronic Kidney Disease (CKD),Glomerular Filtration Rate, Panchkarma, Vataj Pandu, Vrikk Vikar

Abstract

Chronic Kidney Disease (CKD) is a progressive disorder affecting kidney structure and function, often complicated by Type 2 Diabetes Mellitus (T2DM) and hypertension. Early stage CKD is frequently asymptomatic, and management can be challenging, particularly in resource-limited settings due to high costs and limited accessibility of conventional therapies. This case report presents a 67-year-old male patient with CKD, T2DM, and hypertension, treated at Jeena Sikho Lifecare Limited Hospital, Derabassi, India, using a personalized Ayurvedic regimen combined with Panchakarma therapies. Following 12 days of inpatient treatment, the patient demonstrated marked clinical improvements: drowsiness, pedal oedema, eye vision and urine got better. Vital parameters showed gradual stabilization, with body weight decreasing from 83 kg to 76 kg and blood pressure stabilizing from highs of 180/90 mmHg to 120/80 mmHg. Laboratory investigations indicated significant improvements, with hemoglobin increasing from 7.3 gm/dL to 10.0 gm/dL, urea decreasing from 280.12 mg/dL to 100 mg/dL, creatinine declining from 6.10 mg/ dL to 4.5 mg/dL, and total RBC count increasing from 2.61 Mill/Cumm to 3.54 Mill/ Cumm. Uric acid stabilized at 7.1 mg/dL. Renal function assessed by GFR improved, with global GFR from 14.2 to 19.8 ml/min. This case highlights the potential of Ayurveda as an effective, accessible, and affordable approach for managing CKD Stage IV and associated comorbidities, demonstrating improvements in symptoms, vitals, laboratory parameters, and kidney function over a short inpatient treatment period.

References

Francis A, Harhay MN, Ong A, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:1–3.

Jadoul M, Aoun M, Imani MM. The major global burden of chronic kidney disease. Lancet Glob Health. 2024;12(3):e342–3.

Duff R, Awofala O, Arshad MT, Lambourg E, Gallacher P, Dhaun N, et al. Global health inequalities of chronic kidney disease: a meta-analysis. Nephrol Dial Transplant. 2024;gfae048.

Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382–95.

Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India—results from the SEEK study. BMC Nephrol. 2013;14:114.

Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10.

Ubaid M, Mobin A, Manzoor I, Rehan M, Qadri Z. A study on etiology, clinical features and complications of chronic kidney disease patients. Pak J Med Health Sci. 2022;16(10):488.

Roy MP. Correlates of chronic kidney disease in India. SN Compr Clin Med. 2020;2(11):2230–4.

Parameswaran S. Chronic kidney disease in India. Health Sci. 2012;1(2):1–9.

Kumar V, Yadav AK, Sethi J, Ghosh A, Sahay M, Prasad N, et al. The Indian chronic kidney disease (ICKD) study: baseline characteristics. Clin Kidney J. 2022;15(1):60–9.

Dattu MS, Kumar EK, Krishnamurthy S, Reddy YV. Aetiology of chronic kidney disease in rural patients. J Clin Sci Res. 2016;5(4):221–4.

Abraham G, Moorthy AV, Aggarwal V. Chronic kidney disease: a silent epidemic in Indian subcontinent—strategies for management. J Indian Med Assoc. 2006;104(12):689–91.

Agarwal SK, Srivastava RK. Chronic kidney disease in India: challenges and solutions. Nephron Clin Pract. 2009;111(3):c197–203.

Lifestyle, Risk Factors & CKD Progression

Schrauben SJ, Apple BJ, Chang AR. Modifiable lifestyle behaviors and CKD progression: a narrative review. Kidney360. 2022;3(4):752–78.

Guthrie B. Can NSAIDs be used safely for analgesia in patients with CKD? CON. Kidney360. 2020;1(11):1189–91.

Bruce MA, Griffith DM, Thorpe RJ Jr. Stress and the kidney. Adv Chronic Kidney Dis. 2015;22(1):46–53.

Salifu I, Tedla F, Pandey A, Ayoub I, Brown C, McFarlane SI, et al. Sleep duration and chronic kidney disease: analysis of the national health interview survey. Cardiorenal Med. 2014;4(3-4):210–6.

Mallamaci F, Pisano A, Tripepi G. Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial. Nephrol Dial Transplant. 2020;35(Suppl 2):ii18–ii22.

Park J, Lyles RH, Bauer-Wu S. Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. Am J Physiol Regul Integr Comp Physiol. 2014;307(1):R93–101.

Joshi AM, Raveendran AV, Arumugam M. Therapeutic role of yoga in hypertension. World J Methodol. 2024;14(1):90–127.

Gautam S, Kiran UV. Clinical effects of yoga and meditational practices on the holistic health of chronic kidney disease patients: a systematic review. Cureus. 2024;16(4):e57546.

Published

2025-12-27

How to Cite

Case Study on Ayurvedic and Panchkarma Intervention for Chronic Kidney Disease in an Elderly Patient . (2025). Academia Journal of Medicine, 8(2), 60-78. https://doi.org/10.48165/ajm.2025.8.02.12